Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells
- Charles Durand*,†,
- Catherine Robin*,
- Karine Bollerot*,
- Margaret H. Baron‡,
- Katrin Ottersbach*, and
- Elaine Dzierzak*,§
- *Department of Cell Biology and Genetics, Erasmus Medical Center, 3000 CA, Rotterdam, The Netherlands; and
- ‡Departments of Medicine, Molecular, Cell, and Developmental Biology, Gene and Cell Medicine, and Oncological Sciences and The Black Family Stem Cell Institute, Mt. Sinai School of Medicine, New York, NY 10029
-
Edited by Paul A. Marks, Memorial Sloan–Kettering Cancer Center, New York, NY, and approved November 5, 2007 (received for review July 26, 2007)
Abstract
Hematopoietic stem cell (HSC) self-renewal and differentiation is regulated by cellular and molecular interactions with the surrounding microenvironment. During ontogeny, the aorta–gonad–mesonephros (AGM) region autonomously generates the first HSCs and serves as the first HSC-supportive microenvironment. Because the molecular identity of the AGM microenvironment is as yet unclear, we examined two closely related AGM stromal clones that differentially support HSCs. Expression analyses identified three putative HSC regulatory factors, β-NGF (a neurotrophic factor), MIP-1γ (a C–C chemokine family member) and Bmp4 (a TGF-β family member). We show here that these three factors, when added to AGM explant cultures, enhance the in vivo repopulating ability of AGM HSCs. The effects of Bmp4 on AGM HSCs were further studied because this factor acts at the mesodermal and primitive erythropoietic stages in the mouse embryo. In this report, we show that enriched E11 AGM HSCs express Bmp receptors and can be inhibited in their activity by gremlin, a Bmp antagonist. Moreover, our results reveal a focal point of Bmp4 expression in the mesenchyme underlying HSC containing aortic clusters at E11. We suggest that Bmp4 plays a relatively late role in the regulation of HSCs as they emerge in the midgestation AGM.
Footnotes
- §To whom correspondence should be addressed at: Erasmus Medical Center, Department of Cell Biology and Genetics, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. E-mail: e.dzierzak{at}erasmusmc.nl
-
Author contributions: C.D. and C.R. contributed equally to this work; C.D., C.R., and E.D. designed research; C.D., C.R., K.B., and K.O. performed research; M.H.B. contributed new reagents/analytic tools; C.D., C.R., K.B., K.O., and E.D. analyzed data; and C.D. and E.D. wrote the paper.
-
↵ †Present address: Laboratoire de Biologie du Développement, Unité Mixte de Recherche Centre National de la Recherche Scientifique 7622, Université Paris VI, Paris, France.
-
The authors declare no conflict of interest.
-
This article is a PNAS Direct Submission.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0706923105/DC1.
- © 2007 by The National Academy of Sciences of the USA





